October JAAD: Routine rescreening for latent tuberculosis has low utility in patients with chronic immune- mediated inflammatory diseases treated with biologics: A single-center, retrospective cohort study episode artwork

EPISODE · Dec 1, 2022

October JAAD: Routine rescreening for latent tuberculosis has low utility in patients with chronic immune- mediated inflammatory diseases treated with biologics: A single-center, retrospective cohort study

from AAD's Dialogues in Dermatology

Anthony P. Fernandez, MD, FAAD and Urmi Khanna, MD interviewed by Brad Glick, DO, MPH, FAAD

Episode metadata supplied by the publisher feed · Published Dec 1, 2022

Embed this episode

NOW PLAYING

October JAAD: Routine rescreening for latent tuberculosis has low utility in patients with chronic immune- mediated inflammatory diseases treated with biologics: A single-center, retrospective cohort study

0:00 0:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

When was this AAD's Dialogues in Dermatology episode published?

This episode was published on December 1, 2022.

Can I download this AAD's Dialogues in Dermatology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!